# Comparison of Sequential Therapies With Sunitinib and Sorafenib in Advanced Renal Cell Carcinoma

> **NCT01481870** · PHASE3 · UNKNOWN · sponsor: **Yamagata University** · enrollment: 120 (estimated)

## Conditions studied

- Metastatic Renal Cell Carcinoma

## Interventions

- **DRUG:** Sorafenib-sunitinib
- **DRUG:** Sunitinib-sorafenib

## Key facts

- **NCT ID:** NCT01481870
- **Lead sponsor:** Yamagata University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-01
- **Primary completion:** 2013-07
- **Final completion:** 2015-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2013-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01481870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01481870, "Comparison of Sequential Therapies With Sunitinib and Sorafenib in Advanced Renal Cell Carcinoma". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01481870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*